Jonathan Z. Ho

463 total citations
27 papers, 368 citations indexed

About

Jonathan Z. Ho is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Jonathan Z. Ho has authored 27 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 16 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Jonathan Z. Ho's work include Chemical Synthesis and Analysis (7 papers), Click Chemistry and Applications (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Jonathan Z. Ho is often cited by papers focused on Chemical Synthesis and Analysis (7 papers), Click Chemistry and Applications (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Jonathan Z. Ho collaborates with scholars based in United States, Egypt and Kuwait. Jonathan Z. Ho's co-authors include Rafat M. Mohareb, Matthew P. Braun, J. Edward Semple, Tony Gibson, Robert M. Coates, Lijuan Zhu, Henry Rapoport, Tae Bo Sim, Radhey S. Gupta and Jin Hee Ahn and has published in prestigious journals such as Applied and Environmental Microbiology, The Journal of Organic Chemistry and Chemical Research in Toxicology.

In The Last Decade

Jonathan Z. Ho

27 papers receiving 342 citations

Peers

Countries citing papers authored by Jonathan Z. Ho

Since Specialization

Citations

This map shows the geographic impact of Jonathan Z. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Z. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Z. Ho more than expected).

Fields of papers citing papers by Jonathan Z. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Z. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Z. Ho. The network helps show where Jonathan Z. Ho may publish in the future.

Co-authorship network of co-authors of Jonathan Z. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Z. Ho. A scholar is included among the top collaborators of Jonathan Z. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Z. Ho. Jonathan Z. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of distinctive molecular traits that are characteristic of the phylum “Deinococcus-Thermus” and distinguish its main constituent groups 2016 ·Systematic and Applied Microbiology ·Jonathan Z. Ho, Mobolaji Adeolu, (unknown), Radhey S. Gupta	26
2	An efficient synthesis of carbon‐14‐labeled 6‐[2‐(dimethylamino)ethyl]‐14‐(1‐ethylpropyl)‐5,6,7,8‐tetrahydroindolo [2,1‐α] [2,5]benzodiazocine‐11‐carboxylic acid using Curtius rearrangement reaction as a key step 2010 ·Journal of Labelled Compounds and Radiopharmaceuticals ·(unknown), Jonathan Z. Ho, Matthew P. Braun	5
3	Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans 2009 ·Drug Metabolism and Disposition ·Sanjeev Kumar, (unknown), Georgy Hartmann, (unknown), Arthur Bergman, (unknown), Jonathan Z. Ho, (unknown), (unknown), Matthew P. Braun, Bindhu V. Karanam, Dennis Dean, Isaias Noel Gendrano, (unknown), John A. Wagner, Rajesh Krishna	33
4	Pharmacokinetics, Metabolism, and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Rats and Rhesus Monkeys 2009 ·Drug Metabolism and Disposition ·(unknown), Georgy Hartmann, Qing Chen, (unknown), Scott A. Bradley, George A. Doss, (unknown), Jonathan Z. Ho, Matthew P. Braun, Dennis Dean, Wei Tang, Sanjeev Kumar	27
5	Synthesis of a ¹⁴C‐labeled FPTase inhibitor via a Pd‐catalyzed cyanation with Zn(¹⁴CN)₂ and via bromo[¹⁴C]acetic acid 2008 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Jonathan Z. Ho, Charles S. Elmore, Matthew P. Braun	3
6	Applications of LC‐ARC™ stop‐flow radiochemical detection 2007 ·Journal of Labelled Compounds and Radiopharmaceuticals ·David J. Schenk, Jonathan Z. Ho, (unknown), Michael A. Wallace, (unknown), (unknown), (unknown), David G. Melillo	1
7	Cu(I)Br‐mediated preparation of ¹⁴C‐labeled 3‐pyridineacetate derivatives and synthesis of a novel ¹⁴C‐labeled PDE‐IV inhibitor 2007 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Jonathan Z. Ho, Matthew P. Braun	3
8	Cycloaddition approach to the curing of polyimides via precursor containing thiophene‐S,S‐dioxide 2006 ·Heteroatom Chemistry ·Andrew C. Magyarosy, Rafat M. Mohareb, Jonathan Z. Ho	2
9	Bioactivation of 2,3-Diaminopyridine-Containing Bradykinin B₁ Receptor Antagonists: Irreversible Binding to Liver Microsomal Proteins and Formation of Glutathione Conjugates 2005 ·Chemical Research in Toxicology ·Cuyue Tang, Raju Subramanian, Yuhsin Kuo, (unknown), Ping Lü, Scott D. Kuduk, Christina Ng, (unknown), Charles S. Elmore, (unknown), Jonathan Z. Ho, Mark G. Bock, Thomas A. Baillie, Thomayant Prueksaritanont	22
10	Synthesis of ¹³C‐Labeled Pyrazinone Thrombin Inhibitors and Elucidation of Metabolic Activation Pathways 2004 ·Helvetica Chimica Acta ·Jonathan Z. Ho, Matthew P. Braun, Raju Subramanian, Ying‐Duo Gao, Dennis Dean, David G. Melillo	3
11	BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMR 2003 ·Drug Metabolism and Disposition ·Raju Subramanian, (unknown), Jonathan Z. Ho, Steven M. Pitzenberger, Maria Victoria Silva Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, (unknown), Rominder Singh	9
12	An Efficient Procedure for the Preparation of (1S,3R)- and (1S,3S)-1-Amino-3-(hydroxymethyl)cyclopentanes 2003 ·Chemical and Pharmaceutical Bulletin ·Henry Rapoport, (unknown), Rafat M. Mohareb, Jin Hee Ahn, Tae Bo Sim, Jonathan Z. Ho	3
13	Non-covalent thrombin inhibitors featuring p3-heterocycles with P1-monocyclic arginine surrogates 2002 ·Bioorganic & Medicinal Chemistry Letters ·John Reiner, Daniel V. Siev, (unknown), Jingrong Jean Cui, Jonathan Z. Ho, Komandla Malla Reddy, (unknown), (unknown), (unknown), (unknown), Tony Gibson, (unknown), (unknown), Thomas G. Nolan, J. Edward Semple	25
14	Novel, Potent Non-Covalent Thrombin Inhibitors Incorporating P3-Lactam Scaffolds 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan Z. Ho, Tony Gibson, J. Edward Semple	25
15	Non-covalent thrombin inhibitors featuring P3-Heterocycles with P1-Bicyclic arginine surrogates 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jingrong Jean Cui, (unknown), John Reiner, Komandla Malla Reddy, Scott J. Kemp, Jonathan Z. Ho, Daniel V. Siev, (unknown), Tony Gibson, (unknown), (unknown), (unknown), (unknown), Thomas G. Nolan, J. Edward Semple	18
16	Chlorxanthomycin, a Fluorescent, Chlorinated, Pentacyclic Pyrene from a Bacillus sp 2002 ·Applied and Environmental Microbiology ·Andrew C. Magyarosy, Jonathan Z. Ho, Henry Rapoport, Scott C. Dawson, Joe D Hancock, Jay D. Keasling	14
17	Enantiospecific Synthesis of Carbapentostatins 2002 ·The Journal of Organic Chemistry ·Jonathan Z. Ho, Rafat M. Mohareb, Jin Hee Ahn, Tae Bo Sim, Henry Rapoport	32
18	The reaction of 2‐amino‐3‐cyano‐4,5,6,7‐tetrahydrobenzo[b]‐thiophene with diethyl malonate: synthesis of coumarin, pyridine, and thiazole derivatives 2001 ·Heteroatom Chemistry ·Rafat M. Mohareb, (unknown), Jonathan Z. Ho	8
19	Guanylpiperidine peptidomimetics: potent and selective bis-cation inhibitors of factor Xa 2000 ·Bioorganic & Medicinal Chemistry Letters ·Susan Y. Tamura, Odile E. Levy, (unknown), John Reiner, (unknown), Jonathan Z. Ho, (unknown), Peter W. Bergum, Ruth F. Nutt, Terence K. Brunck, J. Edward Semple	12
20	Exploratory solid-phase synthesis of factor Xa inhibitors: Discovery and application of P3-heterocyclic amides as novel types of non-basic arginine surrogates 1999 ·Bioorganic & Medicinal Chemistry Letters ·Jonathan Z. Ho, Odile E. Levy, Tony Gibson, (unknown), J. Edward Semple	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact